IN–VITRO SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO AMOXICILLIN–CLAVULANATE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

VARSHOUCHI M.; RASTGAR MOHAMMAD HOSSEIN; RAFI A.A.N.; NAGILI B.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: ARCHIVES OF CLINICAL INFECTIOUS DISEASES Year:2006 | Volume:1 | Issue:3 Page(s): 121-125

Download Full-Text

View:

246

Download:

156

Cites:

Information Journal Paper

Title

IN–VITRO SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO AMOXICILLIN–CLAVULANATE

Author(s)

VARSHOUCHI M. | RASTGAR MOHAMMAD HOSSEIN | RAFI A.A.N. | NAGILI B. | Issue Writer Certificate

Keywords

MYCOBACTERIUM TUBERCULOSIS

MULTIDRUG RESISTANT

AMOXICILLIN-CLAVULANATE

Abstract

Background: The evidence of rapid spread of multidrug resistant Mycobacterium tuberculosis (MDR–TB) strains especially in high risk communities; persuade clinicians to find new drugs for this problem. b– lactams with few or no side effects has been reviewed as an alternative drugs for this issue. This study carried out to determine the effectiveness of amoxicillin–clavulanate in a group of Iranian patients.Materials and methods: Amoxicillin–clavulanate was studied in five different minimal inhibitory concentrations (32- 512mg/ml) on 90 clinical strains of Mycobacterium tuberculosis (50 strains were sensitive and 40 were resistant to firstline anti-TB drugs).Results: All strains were found resistant to amoxicillin–clavulanate in concentration of 32mg/ml. Only in concentration of 64 mg/ml, sensitive strains (to first-line anti-TB drugs) were significantly more susceptible to amoxicillin–clavulanate than resistant strains. Five different MICs showed a non-significant difference in susceptibility to amoxicillin– clavulanate between strains with various resistance patterns to first-line anti-TB drugs. However, in 29 strains MIC were above 512mg/ml.Conclusion: Although amoxicillin–clavulante might be a suitable candidate as a second-line anti-TB drug, further clinical trials are required to draw a firm conclusion.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

VARSHOUCHI, M., RASTGAR, MOHAMMAD HOSSEIN, RAFI, A.A.N., & NAGILI, B.. (2006). IN–VITRO SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO AMOXICILLIN–CLAVULANATE. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, 1(3), 121-125. SID. https://sid.ir/paper/313550/en

Vancouver: Copy

VARSHOUCHI M., RASTGAR MOHAMMAD HOSSEIN, RAFI A.A.N., NAGILI B.. IN–VITRO SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO AMOXICILLIN–CLAVULANATE. IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES[Internet]. 2006;1(3):121-125. Available from: https://sid.ir/paper/313550/en

IEEE: Copy

M. VARSHOUCHI, MOHAMMAD HOSSEIN RASTGAR, A.A.N. RAFI, and B. NAGILI, “IN–VITRO SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO AMOXICILLIN–CLAVULANATE,” IRANIAN JOURNAL OF CLINICAL INFECTIOUS DISEASES, vol. 1, no. 3, pp. 121–125, 2006, [Online]. Available: https://sid.ir/paper/313550/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops